BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8510101)

  • 1. Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.
    Sircar I; Winters RT; Quin J; Lu GH; Major TC; Panek RL
    J Med Chem; 1993 Jun; 36(12):1735-45. PubMed ID: 8510101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
    Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
    J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptide angiotensin II antagonists: N-phenyl-1H-pyrrole derivatives are angiotensin II receptor antagonists.
    Bovy PR; Reitz DB; Collins JT; Chamberlain TS; Olins GM; Corpus VM; McMahon EG; Palomo MA; Koepke JP; Smits GJ
    J Med Chem; 1993 Jan; 36(1):101-10. PubMed ID: 8421274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfonylureas and sulfonylcarbamates as new non-tetrazole angiotensin II receptor antagonists. Discovery of a highly potent orally active (imidazolylbiphenylyl)sulfonylurea (HR 720).
    Deprez P; Guillaume J; Becker R; Corbier A; Didierlaurent S; Fortin M; Frechet D; Hamon G; Heckmann B; Heitsch H
    J Med Chem; 1995 Jun; 38(13):2357-77. PubMed ID: 7608902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids.
    Keenan RM; Weinstock J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Hill DT; Morgan TM; Samanen JM; Peishoff CE
    J Med Chem; 1993 Jun; 36(13):1880-92. PubMed ID: 8515425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
    J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of potent nonpeptide angiotensin II receptor antagonists: a new class of potent antihypertensives.
    Duncia JV; Chiu AT; Carini DJ; Gregory GB; Johnson AL; Price WA; Wells GJ; Wong PC; Calabrese JC; Timmermans PB
    J Med Chem; 1990 May; 33(5):1312-29. PubMed ID: 2329553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
    Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
    Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on nonpeptide angiotensin II receptor antagonists. IV. Synthesis and biological evaluation of 4-acrylamide-1H-imidazole derivatives.
    Okazaki T; Watanabe T; Kikuchi K; Suga A; Shibasaki M; Fujimori A; Inagaki O; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):973-81. PubMed ID: 9658576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists.
    Bernhart CA; Perreaut PM; Ferrari BP; Muneaux YA; Assens JL; Clément J; Haudricourt F; Muneaux CF; Taillades JE; Vignal MA
    J Med Chem; 1993 Oct; 36(22):3371-80. PubMed ID: 8230127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.
    Bühlmayer P; Criscione L; Fuhrer W; Furet P; de Gasparo M; Stutz S; Whitebread S
    J Med Chem; 1991 Oct; 34(10):3105-14. PubMed ID: 1920360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.
    Kubo K; Inada Y; Kohara Y; Sugiura Y; Ojima M; Itoh K; Furukawa Y; Nishikawa K; Naka T
    J Med Chem; 1993 Jun; 36(12):1772-84. PubMed ID: 8510105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New nonpeptide angiotensin II receptor antagonists. 2. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)quinoline derivatives.
    Bradbury RH; Allott CP; Dennis M; Fisher E; Major JS; Masek BB; Oldham AA; Pearce RJ; Rankine N; Revill JM
    J Med Chem; 1992 Oct; 35(22):4027-38. PubMed ID: 1433210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists.
    Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT
    J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730
    [No Abstract]   [Full Text] [Related]  

  • 15. New nonpeptide angiotensin II receptor antagonists. 3. Synthesis, biological properties, and structure-activity relationships of 2-alkyl-4-(biphenylylmethoxy)pyridine derivatives.
    Bradbury RH; Allott CP; Dennis M; Girdwood JA; Kenny PW; Major JS; Oldham AA; Ratcliffe AH; Rivett JE; Roberts DA
    J Med Chem; 1993 Apr; 36(9):1245-54. PubMed ID: 8487261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally restricted polysubstituted biphenyl derivatives with angiotensin II receptors antagonist properties.
    Bovy PR; Collins JT; Olins GM; McMahon EG; Hutton WC
    J Med Chem; 1991 Aug; 34(8):2410-4. PubMed ID: 1875338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide angiotensin II antagonists derived from 1H-pyrazole-5-carboxylates and 4-aryl-1H-imidazole-5-carboxylates.
    Ashton WT; Hutchins SM; Greenlee WJ; Doss GA; Chang RS; Lotti VJ; Faust KA; Chen TB; Zingaro GJ; Kivlighn SD
    J Med Chem; 1993 Nov; 36(23):3595-605. PubMed ID: 8246227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W; Mauz AB; Van Meel JC; Entzeroth M
    Mol Pharmacol; 1992 Jun; 41(6):1081-8. PubMed ID: 1614410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.
    Keenan RM; Weinstock J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Hill DT; Morgan TM; Samanen JM; Hempel J
    J Med Chem; 1992 Oct; 35(21):3858-72. PubMed ID: 1433195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New nonpeptide angiotensin II receptor antagonists. 1. Synthesis, biological properties, and structure-activity relationships of 2-alkyl benzimidazole derivatives.
    Thomas AP; Allott CP; Gibson KH; Major JS; Masek BB; Oldham AA; Ratcliffe AH; Roberts DA; Russell ST; Thomason DA
    J Med Chem; 1992 Mar; 35(5):877-85. PubMed ID: 1548677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.